Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12573)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2014 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ma L, Chua MS, Andrisani O, So S. Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. World J Gastroenterol 2014; 20(2): 333-345 [PMID: 24574704 DOI: 10.3748/wjg.v20.i2.333] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i2/333.htm |
| Number | Citing Articles |
| 1 |
Braira Wahid, Amjad Ali, Shazia Rafique, Muhammad Idrees. New Insights into the Epigenetics of Hepatocellular Carcinoma. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1609575
|
| 2 |
Hong-ye Jiang, Gang Ning, Yen-sheng Wang, Wei-biao Lv. 14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9762067
|
| 3 |
Mai Thanh Binh, Nghiem Xuan Hoan, Dao Phuong Giang, Hoang Van Tong, C.-Thomas Bock, Heiner Wedemeyer, Nguyen Linh Toan, Mai Hong Bang, Peter G. Kremsner, Christian G. Meyer, Le Huu Song, Thirumalaisamy P. Velavan. Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59667-z
|
| 4 |
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies. 2022; : 761 doi: 10.1007/978-3-030-41683-6_50
|
| 5 |
Xian Qin, Jing Chen, Long Wu, Zhisu Liu. MiR-30b-5p acts as a tumor suppressor, repressing cell proliferation and cell cycle in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2017; 89: 742 doi: 10.1016/j.biopha.2017.02.062
|
| 6 |
Mohamed H. Yousef, Hassan A. N. El-Fawal, Anwar Abdelnaser, Junyan Tao. Hepigenetics: A Review of Epigenetic Modulators and Potential Therapies in Hepatocellular Carcinoma. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/9593254
|
| 7 |
YUJI INAGAKI, KATSUYA SHIRAKI, KAZUSHI SUGIMOTO, TAKAZUMI YADA, MASAHIKO TAMEDA, SUGURU OGURA, NORIHIKO YAMAMOTO, YOSHIYUKI TAKEI, MASAAKI ITO. Epigenetic regulation of proliferation and invasion in hepatocellular carcinoma cells by CBP/p300 histone acetyltransferase activity. International Journal of Oncology 2016; 48(2): 533 doi: 10.3892/ijo.2015.3288
|
| 8 |
XIAOJIAO ZHANG, JUN ZHANG, RUI WANG, SHICHENG GUO, HUILU ZHANG, YANYUN MA, QINGMEI LIU, HAIYAN CHU, XIANGHONG XU, YITONG ZHANG, DONGQIN YANG, JIUCUN WANG, JIE LIU. Hypermethylation reduces the expression of PNPLA7 in hepatocellular carcinoma. Oncology Letters 2016; 12(1): 670 doi: 10.3892/ol.2016.4660
|
| 9 |
|
| 10 |
Hongye Jiang, Gang Ning, Yensheng Wang, Weibiao Lv, Andrea Maugeri. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response. Disease Markers 2021; 2021: 1 doi: 10.1155/2021/5576683
|
| 11 |
Sathish Kumar Mungamuri, Vijay Aditya Mavuduru. Role of epigenetic alterations in aflatoxin‐induced hepatocellular carcinoma. Liver Cancer International 2020; 1(2): 41 doi: 10.1002/lci2.20
|
| 12 |
Silvia Udali, Patrizia Guarini, Sara Moruzzi, Andrea Ruzzenente, Stephanie A. Tammen, Alfredo Guglielmi, Simone Conci, Patrizia Pattini, Oliviero Olivieri, Roberto Corrocher, Sang‐Woon Choi, Simonetta Friso. Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate. Hepatology 2015; 62(2): 496 doi: 10.1002/hep.27823
|
| 13 |
Sahar Olsadat Sajadian, Chaturvedula Tripura, Fazel Sahraneshin Samani, Marc Ruoss, Steven Dooley, Hossein Baharvand, Andreas K. Nussler. Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7. Clinical Epigenetics 2016; 8(1) doi: 10.1186/s13148-016-0213-6
|
| 14 |
|
| 15 |
Dan-Dan Wan, Xiao-Ju Li, Xing-Ru Wang, Tian-Xi Liu. Metachronous multifocal carcinoma: A case report. World Journal of Gastrointestinal Oncology 2024; 16(7): 3350-3356 doi: 10.4251/wjgo.v16.i7.3350
|
| 16 |
Bin-yong Liang, Min Xiong, Gui-bao Ji, Er-lei Zhang, Zun-yi Zhang, Ke-shuai Dong, Xiao-ping Chen, Zhi-yong Huang. Synergistic suppressive effect of PARP-1 inhibitor PJ34 and HDAC inhibitor SAHA on proliferation of liver cancer cells. Journal of Huazhong University of Science and Technology [Medical Sciences] 2015; 35(4): 535 doi: 10.1007/s11596-015-1466-6
|
| 17 |
Saleh Daher, Muhammad Massarwa, Ariel A. Benson, Tawfik Khoury. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. Journal of Clinical and Translational Hepatology 2018; 6(1): 1 doi: 10.14218/JCTH.2017.00031
|
| 18 |
Dan Wang, Chendong Yang, Zhuien Wang, Yi Yang, Defang Li, Xiaojie Ding, Wenjuan Xu, Qiusheng Zheng. RETRACTED ARTICLE: Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09668-2
|
| 19 |
Jun Zhao, Steven G. Gray, Martin Wabitsch, Catherine M. Greene, Matthew W. Lawless. The therapeutic properties of resminostat for hepatocellular carcinoma. Oncoscience 2018; 5(5-6): 196 doi: 10.18632/oncoscience.420
|
| 20 |
Jose Arriola-Montenegro, Renato Beas, Renato Cerna-Viacava, Andres Chaponan-Lavalle, Karla Hernandez Randich, Diego Chambergo-Michilot, Herson Flores Sanga, Pornthira Mutirangura. Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease. World Journal of Cardiology 2023; 15(7): 328-341 doi: 10.4330/wjc.v15.i7.328
Abstract(624) |
Core Tip(410) |
Full Article(HTML)(2458)
|
Full Article with Cover (PDF)-1468K(101)
|
Full Article (Word)-335K(88)
|
Audio-441K(1)
|
Peer-Review Report-231K(54)
|
Answering Reviewers-167K(49)
|
Full Article (PDF)-1214K(422)
|
Full Article (XML)-257K(63)
|
Times Cited (2)
|
Total Visits (6207)
|
Open
|
| 21 |
Renato Heidor, Ernesto Vargas-Mendez, Fernando Salvador Moreno. Epigenetics of Cancer Prevention. 2019; : 231 doi: 10.1016/B978-0-12-812494-9.00011-1
|
| 22 |
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies. Cancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
|
| 23 |
Hao Liang, Mingxing Xu, Zhiyong Xiong, Kunpeng Hu, Jiarui Yang, Mingbo Cao, Zhaozhong Zhong, Zhicheng Yao, Meihai Deng, Bo Liu. Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma. Aging 2021; 13(4): 6115 doi: 10.18632/aging.202606
|
| 24 |
Luca Sanna, Irene Marchesi, Mariarosa A. B. Melone, Luigi Bagella. The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma. Journal of Cellular Physiology 2018; 233(9): 6508 doi: 10.1002/jcp.26545
|
| 25 |
Surya Sukumaran, Mingdian Tan, Shulamit Fluss Ben-Uliel, Hui Zhang, Marta De Zotti, Mei-Sze Chua, Samuel K. So, Nir Qvit. Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma. Computational and Structural Biotechnology Journal 2023; 21: 3159 doi: 10.1016/j.csbj.2023.05.023
|
| 26 |
Jingting Kang, Jie Wang, Jin Cheng, Zhiliang Cao, Ran Chen, Huiyu Li, Shuang Liu, Xiangmei Chen, Jianhua Sui, Fengmin Lu. Down-regulation of NTCP expression by cyclin D1 in hepatitis B virus-related hepatocellular carcinoma has clinical significance. Oncotarget 2017; 8(34): 56041 doi: 10.18632/oncotarget.10241
|
| 27 |
Ke Shi, Jie Hou, Qun Zhang, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Neutrophil-to-high-density-lipoprotein-cholesterol ratio and mortality among patients with hepatocellular carcinoma. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1127913
|
| 28 |
Gang Ning, Yan-Lin Huang, Li-Min Zhen, Wen-Xiong Xu, Qian Jiao, Fang-Ji Yang, Li-Na Wu, Yong-Yuan Zheng, Jie Song, Yen-Sheng Wang, Chan Xie, Liang Peng. Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients. Aging 2018; 10(11): 3450 doi: 10.18632/aging.101658
|
| 29 |
Aya El Khodiry, Menna Afify, Hend M El Tayebi. Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis. World Journal of Gastroenterology 2018; 24(5): 549-572 doi: 10.3748/wjg.v24.i5.549
|
| 30 |
Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305
|
| 31 |
Gislaine Dionísio Ferreira, Glaucia Maria de Mendonça Fernandes, Camila Penteado, Vivian Romanholi Cória, Ana Lívia da Silva Galbiatti-Dias, Anelise Russo, Márcia Maria Urbanin Castanhole-Nunes, Renato Ferreira da Silva, Rita de Cássia Martins Alves da Silva, Érika Cristina Pavarino, Mariangela Torreglosa Ruiz Cintra, Eny Maria Goloni-Bertollo. Polymorphisms in xenobiotic metabolism-related genes in patients with hepatocellular carcinoma: a case–control study. Xenobiotica 2021; 51(6): 737 doi: 10.1080/00498254.2021.1893408
|
| 32 |
Jin Sun, Beibei Bie, Shu Zhang, Jun Yang, Zongfang Li. Long Non-Coding RNAs: Critical Players in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2014; 15(11): 20434 doi: 10.3390/ijms151120434
|
| 33 |
Yong-Ru Liu, Rui-Xue Tang, Wen-Ting Huang, Fang-Hui Ren, Rong-Quan He, Li-Hua Yang, Dian-Zhong Luo, Yi-Wu Dang, Gang Chen. Long noncoding RNAs in hepatocellular carcinoma: Novel insights into their mechanism. World Journal of Hepatology 2015; 7(28): 2781-2791 doi: 10.4254/wjh.v7.i28.2781
|
| 34 |
Venkat Bhat, Sujitha Srinathan, Elisa Pasini, Marc Angeli, Emily Chen, Cristina Baciu, Mamatha Bhat. Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis. World Journal of Hepatology 2018; 10(1): 155-165 doi: 10.4254/wjh.v10.i1.155
|
| 35 |
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Zeinab Ahsani, Mahdi Paryan. Bioinformatics prediction and experimental validation of microRNA-20a targeting Cyclin D1 in hepatocellular carcinoma. Tumor Biology 2017; 39(4): 101042831769836 doi: 10.1177/1010428317698361
|
| 36 |
Xiaopeng Cai, Jiaming Zhou, Jingwen Deng, Zhi Chen. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02413-w
|
| 37 |
T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. Clinical Microbiology and Infection 2016; 22(10): 853 doi: 10.1016/j.cmi.2016.07.019
|
| 38 |
Roseane Guimarães Ferreira, Magda Vieira Cardoso, Karine Maria de Souza Furtado, Kaio Murilo Monteiro Espíndola, Ruanderson Pereira Amorim, Marta Chagas Monteiro. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma. Translational Research 2019; 204: 51 doi: 10.1016/j.trsl.2018.09.001
|
| 39 |
Ahmed H. F. El-Tawdi, Marwa Matboli, Sarah El-Nakeep, Ahmed E. M. Azazy, Omar Abdel-Rahman. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2016; 10(7): 869 doi: 10.1080/17474124.2016.1193003
|
| 40 |
|
| 41 |
Xinye Qian, Zhoujing Yang, Lu Gao, Yipiao Liu, Jun Yan. The role of complement in the clinical course of hepatocellular carcinoma. Immunity, Inflammation and Disease 2022; 10(3) doi: 10.1002/iid3.569
|
| 42 |
M.G. Fernandez-Barrena, C.L. Pin. Chromatin Signaling and Diseases. 2016; : 365 doi: 10.1016/B978-0-12-802389-1.00020-4
|
| 43 |
Kaveri Sidhu, Neetu Rohit Kapoor, Vijaya Pandey, Vijay Kumar. The “Macro” World of microRNAs in Hepatocellular Carcinoma. Frontiers in Oncology 2015; 5 doi: 10.3389/fonc.2015.00068
|
| 44 |
Didier Meseure, Kinan Drak Alsibai, Andre Nicolas, Ivan Bieche, Antonin Morillon. Long Noncoding RNAs as New Architects in Cancer Epigenetics, Prognostic Biomarkers, and Potential Therapeutic Targets. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/320214
|
| 45 |
Xuefeng Kan, Wanli Zhang, Ruxu You, Yanfeng Niu, Jianrong Guo, Jun Xue. Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice. BMC Complementary and Alternative Medicine 2017; 17(1) doi: 10.1186/s12906-016-1551-9
|
| 46 |
Jun Zhao, Steven G. Gray, Catherine M. Greene, Matthew W. Lawless. Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(3): 247 doi: 10.1080/17474124.2019.1568870
|
| 47 |
Verona Buocikova, Ivan Rios-Mondragon, Eleftherios Pilalis, Aristotelis Chatziioannou, Svetlana Miklikova, Michal Mego, Karlis Pajuste, Martins Rucins, Naouale El Yamani, Eleonora Marta Longhin, Arkadij Sobolev, Muriel Freixanet, Victor Puntes, Aiva Plotniece, Maria Dusinska, Mihaela Roxana Cimpan, Alena Gabelova, Bozena Smolkova. Epigenetics in Breast Cancer Therapy—New Strategies and Future Nanomedicine Perspectives. Cancers 2020; 12(12): 3622 doi: 10.3390/cancers12123622
|
| 48 |
Shahrzad Movafagh, Amanda Munson. Epigenetics of Cancer Prevention. 2019; : 75 doi: 10.1016/B978-0-12-812494-9.00004-4
|
| 49 |
R. Heidor, J. M. Affonso, T. P. Ong, F. S. Moreno. Nutrition and Cancer Prevention. 2019; : 339 doi: 10.1039/9781788016506-00339
|
| 50 |
Smriti Verma, Bidya Dhar Sahu, Madhav Nilakanth Mugale. Role of lncRNAs in hepatocellular carcinoma. Life Sciences 2023; 325: 121751 doi: 10.1016/j.lfs.2023.121751
|
| 51 |
Yi-Ru Chen, Su-Shan Ouyang, Yan-Ling Chen, Ping Li, Hui-Wen Xu, Sen-Lin Zhu. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma. Aging 2020; 12(17): 17541 doi: 10.18632/aging.103768
|
| 52 |
Yi-Gang Wang, Pan-Pan Huang, Rong Zhang, Bu-Yun Ma, Xiu-Mei Zhou, Yan-Fang Sun. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. World Journal of Gastroenterology 2016; 22(1): 326-337 doi: 10.3748/wjg.v22.i1.326
|
| 53 |
Desirée Bartolini, Katiuscia Dallaglio, Pierangelo Torquato, Marta Piroddi, Francesco Galli. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma. Translational Research 2018; 193: 54 doi: 10.1016/j.trsl.2017.11.007
|
| 54 |
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCC. Hepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
|
| 55 |
Ke Shi, Yufei Bi, Xuanwei Zeng, Xianbo Wang. Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1163304
|
| 56 |
Zhenjing Shi, Ya Luo, Minghui Zhu, Yu Zhou, Bingru Zheng, Daoyi Wu, Shuting Wang, Xiangbang Xie, Heping Lin, Xixiang Yu. Expression Analysis of Long Non-Coding RNA HAR1A and HAR1B in HBV-Induced Hepatocullular Carcinoma in Chinese Patients. Laboratory Medicine 2019; 50(2): 150 doi: 10.1093/labmed/lmy055
|
| 57 |
Chit Tam, Jack Ho Wong, Stephen Kwok Wing Tsui, Tao Zuo, Ting Fung Chan, Tzi Bun Ng. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Applied Microbiology and Biotechnology 2019; 103(12): 4649 doi: 10.1007/s00253-019-09837-5
|
| 58 |
Ioannis Anestopoulos, Georgia Persephoni Voulgaridou, Alexandros G. Georgakilas, Rodrigo Franco, Aglaia Pappa, Mihalis I. Panayiotidis. Epigenetic therapy as a novel approach in hepatocellular carcinoma. Pharmacology & Therapeutics 2015; 145: 103 doi: 10.1016/j.pharmthera.2014.09.005
|
| 59 |
Q Xu, F Deng, Y Qin, Z Zhao, Z Wu, Z Xing, A Ji, Q J Wang. Long non-coding RNA regulation of epithelial–mesenchymal transition in cancer metastasis. Cell Death & Disease 2016; 7(6): e2254 doi: 10.1038/cddis.2016.149
|
| 60 |
Jie Li, Mengxi Liu. Aflatoxin B1 Occurrence, Detection and Toxicological Effects. 2020; doi: 10.5772/intechopen.88353
|
| 61 |
Adane Adugna. Histomolecular characterisation of hepatitis B virus induced liver cancer. Reviews in Medical Virology 2023; 33(6) doi: 10.1002/rmv.2485
|
| 62 |
Shan Lu, Ziqi Meng, Yingying Tan, Chao Wu, Zhihong Huang, Jiaqi Huang, Changgeng Fu, Antony Stalin, Siyu Guo, Xinkui Liu, Leiming You, Xiaojiaoyang Li, Jingyuan Zhang, Wei Zhou, Xiaomeng Zhang, Miaomiao Wang, Jiarui Wu. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification. BMC Complementary Medicine and Therapies 2022; 22(1) doi: 10.1186/s12906-022-03530-3
|
| 63 |
Sheng-xian Yuan, Jin Zhang, Qing-guo Xu, Yuan Yang, Wei-ping Zhou. Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma. Cancer Letters 2016; 379(2): 239 doi: 10.1016/j.canlet.2015.08.008
|
| 64 |
Hye Seung Lee, Wonkyung Jung, Eunjung Lee, Hyeyoon Chang, Jin Hyuk Choi, Han Gyeom Kim, Aeree Kim, Baek-hui Kim. SIRT7, H3K18ac, and ELK4 Immunohistochemical Expression in Hepatocellular Carcinoma. Journal of Pathology and Translational Medicine 2016; 50(5): 337 doi: 10.4132/jptm.2016.05.20
|
| 65 |
Bingxin Lei, Hongxiao Song, Fengchao Xu, Qi Wei, Fei Wang, Guangyun Tan, Haichun Ma. When does hepatitis B virus meet long-stranded noncoding RNAs?. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.962186
|
| 66 |
Aiyao Wang, Jun Meng, Hui Liu, Chen Li, Zhiyong Zhou. Long non‑coding RNA BCAR4 promotes liver cancer progression by regulating proliferation, migration and invasion. Oncology Letters 2020; 20(3): 2779 doi: 10.3892/ol.2020.11826
|
| 67 |
Monica Valente, Alessia Covre, Anna Maria Di Giacomo, Michele Maio. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_50-1
|
| 68 |
Kurt Sartorius, Ping An, Cheryl Winkler, Anil Chuturgoon, Xiaodong Li, Julia Makarova, Anna Kramvis. The Epigenetic Modulation of Cancer and Immune Pathways in Hepatitis B Virus-Associated Hepatocellular Carcinoma: The Influence of HBx and miRNA Dysregulation. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.661204
|
| 69 |
Ting Zhang, Linglin Zhao, Shengyuan Zeng, Lu Bai, Junxia Chen, Zheng Zhang, Yalan Wang, Changzhu Duan. UHRF2 decreases H3K9ac expression by interacting with it through the PHD and SRA/YDG domain in HepG2 hepatocellular carcinoma cells. International Journal of Molecular Medicine 2017; 39(1): 126 doi: 10.3892/ijmm.2016.2805
|
| 70 |
Yao Liu, Ying Feng, Yuxin Li, Ying Hu, Qun Zhang, Yunyi Huang, Ke Shi, Chongping Ran, Jie Hou, Guiqin Zhou, Xianbo Wang. Chlorogenic Acid Decreases Malignant Characteristics of Hepatocellular Carcinoma Cells by Inhibiting DNMT1 Expression. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00867
|
| 71 |
Parvin Zamani, Maryam Matbou Riahi, Amir Abbas Momtazi-Borojeni, Khadijeh Jamialahmadi. Gankyrin: a novel promising therapeutic target for hepatocellular carcinoma. Artificial Cells, Nanomedicine, and Biotechnology 2018; 46(7): 1301 doi: 10.1080/21691401.2017.1388250
|
| 72 |
Angela Cozma, Adriana Fodor, Romana Vulturar, Adela-Viviana Sitar-Tăut, Olga Hilda Orăşan, Flaviu Mureşan, Cezar Login, Ramona Suharoschi. DNA Methylation and Micro-RNAs: The Most Recent and Relevant Biomarkers in the Early Diagnosis of Hepatocellular Carcinoma. Medicina 2019; 55(9): 607 doi: 10.3390/medicina55090607
|
| 73 |
Zhifei Lin, Huliang Jia, Liang Hong, Yahui Zheng, Weiqin Shao, Xudong Ren, Wenwei Zhu, Lu Lu, Ming Lu, Jubo Zhang, Jinhong Chen. Prognostic impact of SET domain‑containing protein 8 and protein arginine methyltransferase 5 in patients with hepatocellular carcinoma following curative resection. Oncology Letters 2018; doi: 10.3892/ol.2018.9083
|
| 74 |
Patrick Wellington da Silva dos Santos, Ana Rita Thomazela Machado, Rone Aparecido De Grandis, Diego Luis Ribeiro, Katiuska Tuttis, Marco Morselli, Alexandre Ferro Aissa, Matteo Pellegrini, Lusânia Maria Greggi Antunes. Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food and Chemical Toxicology 2020; 136: 111047 doi: 10.1016/j.fct.2019.111047
|
| 75 |
Volkan Ince, Tevfik Tolga Sahin, Sami Akbulut, Sezai Yilmaz. Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria. World Journal of Clinical Cases 2022; 10(29): 10413-10427 doi: 10.12998/wjcc.v10.i29.10413
|
| 76 |
Ting Lin, Jingxian Gu, Kai Qu, Xing Zhang, Xiaohua Ma, Runchen Miao, Xiaohong Xiang, Yunong Fu, Wenquan Niu, Junjun She, Chang Liu. A new risk score based on twelve hepatocellular carcinoma-specific gene expression can predict the patients’ prognosis. Aging 2018; 10(9): 2480 doi: 10.18632/aging.101563
|
| 77 |
Jiansong Wu, Qiang Niu, Jie Yuan, Xiaodan Xu, Liuxia Cao. lncRNA‑CD160 decreases the immunity of CD8+ T cells through epigenetic mechanisms in hepatitis B virus infection. Oncology Letters 2020; doi: 10.3892/ol.2020.11534
|